Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Petra J. Woestenberg"'
Autor:
Marianne A B van der Sande, M. Hooiveld, Tessa M Schurink van 't Klooster, Christian J. P. A. Hoebe, Birgit H B van Benthem, Petra J. Woestenberg, Johannes A. Bogaards, Alejandra E Guevara Morel
Publikováno v:
Clinical Infectious Diseases, 73(2), 291-297. Oxford University Press
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Woestenberg, P J, Guevara Morel, A E, Bogaards, J A, Hooiveld, M, Schurink-Van 't Klooster, T M, Hoebe, C J P A, Van Der Sande, M A B & Van Benthem, B H B 2021, ' Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients ', Clinical Infectious Diseases, vol. 73, no. 2, pp. 291-297 . https://doi.org/10.1093/cid/ciaa582
Clinical Infectious Diseases, 73(2), 291-297
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Woestenberg, P J, Guevara Morel, A E, Bogaards, J A, Hooiveld, M, Schurink-Van 't Klooster, T M, Hoebe, C J P A, Van Der Sande, M A B & Van Benthem, B H B 2021, ' Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients ', Clinical Infectious Diseases, vol. 73, no. 2, pp. 291-297 . https://doi.org/10.1093/cid/ciaa582
Clinical Infectious Diseases, 73(2), 291-297
Background There is ongoing debate about the possible protective effect of the bivalent human papillomavirus (2vHPV) vaccine, targeting oncogenic types HPV-16/18, against anogenital warts (AGWs), commonly attributed to HPV-6/11. We performed a retros
Autor:
Petra J. Woestenberg, Audrey J. King, Johannes Berkhof, Hester E. de Melker, Joske Hoes, Christian J. P. A. Hoebe, Marianne A B van der Sande, Birgit H B van Benthem, Johannes A. Bogaards
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases, 72(5), E103-E111
Clinical Infectious Diseases, 72(5), E103-E111. Oxford University Press
Medical Microbiological Laboratories and Public Health Services 2021, ' Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects ', Clinical Infectious Diseases, vol. 72, no. 5, pp. E103-E111 . https://doi.org/10.1093/cid/ciaa1770
Clinical Infectious Diseases, 72(5), E103-E111
Clinical Infectious Diseases, 72(5), E103-E111. Oxford University Press
Medical Microbiological Laboratories and Public Health Services 2021, ' Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects ', Clinical Infectious Diseases, vol. 72, no. 5, pp. E103-E111 . https://doi.org/10.1093/cid/ciaa1770
Background Human papillomavirus (HPV) vaccination programs achieve substantial population-level impact, with effects extending beyond protection of vaccinated individuals. We assessed trends in HPV prevalence up to 8 years postvaccination among men a
Autor:
Pascal van der Weele, Audrey J. King, Johannes A. Bogaards, Petra J. Woestenberg, Birgit H B van Benthem
Publikováno v:
The Journal of Infectious Diseases
Journal of Infectious Diseases, 220(7), 1141-1146. Oxford University Press
Journal of Infectious Diseases, 220(7), 1141-1146. Oxford University Press
To substantiate cross-protection reported across AS04-adjuvanted bivalent human papillomavirus (HPV) vaccine (2vHPV) studies, we reevaluated vaccine effectiveness against type-specific HPV positivity as a function of phylogenetic distance to vaccine
Autor:
Stephen E Hawes, Isabelle Etienney, Joaquín Burgos, Maria Gabriella Donà, Vitaly Smelov, Carmen Hidalgo-Tenorio, Gad Murenzi, Alexandra de Pokomandy, Andrew C. Hickey, Suwat Chariyalertsak, Nittaya Phanuphak, Gary M. Clifford, Huachun Zou, Nicolas Wentzensen, Simbarashe Chinyowa, Gypsyamber D'Souza, Eric P F Chow, Alice M. Schofield, Evy Yunihastuti, Yoojin Choi, Alexandra L. Hernandez, Stephen E. Goldstone, Hélène Péré, Elissa Meites, Yifei Hu, Petra J. Woestenberg, Rebecca G. Nowak, Marleny Valencia Arredondo, Jason J. Ong, Xing Liu, Lei Gao, Ulrike Wieland, Anna R. Giuliano, Feixue Wei, Mauricio Iribarren Díaz, Shu Hsing Cheng, Ningshao Xia, Catharina J Alberts, Jianghong Dai, Yin Ling Woo, Admire Chikandiwa, Michael M. Gaisa, Carol Strong, Marta del Pino, Angella Charnot-Katsikas, Karin Neukam, Maarten F. Schim van der Loeff, Timothy J. Wilkin, I. Mary Poynten, Alan G. Nyitray, Ana P. Ortiz, Michel Segondy, Jean Damien Combes, Valentine Marie Ferré
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Scientia
The Lancet. HIV
The Lancet HIV, 8(9), e531-e543. Elsevier Limited
instname
Scientia
The Lancet. HIV
The Lancet HIV, 8(9), e531-e543. Elsevier Limited
[Background] Robust age-specific estimates of anal human papillomavirus (HPV) and high-grade squamous intraepithelial lesions (HSIL) in men can inform anal cancer prevention efforts. We aimed to evaluate the age-specific prevalence of anal HPV, HSIL,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21c8e9e99b6fc0efa1f1142e5eef6a4f
http://hdl.handle.net/10261/266402
http://hdl.handle.net/10261/266402
Autor:
Tim T. Severs, Naomi van Marm-Wattimena, Petra J. Woestenberg, Johannes A. Bogaards, Kahren van Eer, Audrey J. King, Suzan Leussink
Publikováno v:
Journal of Clinical Microbiology. 58
Human papillomavirus (HPV) epidemiological and vaccine studies require highly sensitive HPV detection systems. The widely used broad-spectrum SPF10-DEIA-LiPA25 (SPF10 method) has reduced sensitivity towards HPV-45 and -59. Therefore, anogenital sampl
Autor:
Fiona R. M. van der Klis, Audrey J. King, Suzan Leussink, Hella Pasmans, Birgit H B van Benthem, Petra J. Woestenberg, Johannes A. Bogaards, Christian J. P. A. Hoebe, Marianne A B van der Sande
Publikováno v:
Vaccine, 38(17), 3321-3329. Elsevier BV
Vaccine, 38(17), 3321-3329. ELSEVIER SCI LTD
Woestenberg, P J, van Benthem, B H B, Bogaards, J A, King, A J, van der Klis, F R M, Pasmans, H, Leussink, S, van der Sande, M A B & Hoebe, C J P A 2020, ' HPV infections among young MSM visiting sexual health centers in the Netherlands : Opportunities for targeted HPV vaccination ', Vaccine, vol. 38, no. 17, pp. 3321-3329 . https://doi.org/10.1016/j.vaccine.2020.03.002
Vaccine, 38(17), 3321-3329. ELSEVIER SCI LTD
Woestenberg, P J, van Benthem, B H B, Bogaards, J A, King, A J, van der Klis, F R M, Pasmans, H, Leussink, S, van der Sande, M A B & Hoebe, C J P A 2020, ' HPV infections among young MSM visiting sexual health centers in the Netherlands : Opportunities for targeted HPV vaccination ', Vaccine, vol. 38, no. 17, pp. 3321-3329 . https://doi.org/10.1016/j.vaccine.2020.03.002
Introduction: In 2009, girls-only HPV16/18 vaccination was introduced in the Netherlands which has achieved 46-61% uptake. Heterosexual men have benefitted from herd protection, but it is unknown whether men who have sex with men (MSM) also benefit f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fead32d96195767da50afa9631b4adb3
https://research.vumc.nl/en/publications/84416eeb-f1a1-430c-a18a-3ddb890f8aef
https://research.vumc.nl/en/publications/84416eeb-f1a1-430c-a18a-3ddb890f8aef
Autor:
Petra J. Woestenberg, Joske Hoes, A. J. King, Gina Ogilvie, Chris J.L.M. Meijer, Robine Donken, M.J. Knol, Simon Dobson, Johannes A. Bogaards, H.E. de Melker, Joel Singer
Publikováno v:
Donken, R, Hoes, J, Knol, M J, Ogilvie, G S, Dobson, S, King, A J, Singer, J, Woestenberg, P J, Bogaards, J A, Meijer, C J L M & De Melker, H E 2020, ' Measuring vaccine effectiveness against persistent HPV infections : a comparison of different statistical approaches ', BMC Infectious Diseases, vol. 20, no. 1, 482 . https://doi.org/10.1186/s12879-020-05083-7
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Infectious Diseases, 20(1):482. BioMed Central
BMC Infectious Diseases
BMC Infectious Diseases, 20(1):482. BioMed Central Ltd
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Infectious Diseases, 20(1):482. BioMed Central
BMC Infectious Diseases
BMC Infectious Diseases, 20(1):482. BioMed Central Ltd
Background Persistent high-risk human papillomavirus (HPV) infection is endorsed by the World Health Organization as an intermediate endpoint for evaluating HPV vaccine effectiveness/efficacy. There are different approaches to estimate the vaccine ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd6816bbdbbcfa1b51f8984ecc1ec90c
Autor:
Petra J. Woestenberg
In men and women, infection with the human papilloma virus (HPV) can lead to cancer, cervical cancer being the most common. Since 2009, HPV vaccination has been offered to girls in the Netherlands. The vaccine that is used is directed against the two
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::759e334f9f61bcd0a9d4871c9c6f802a
https://cris.maastrichtuniversity.nl/en/publications/67c56a38-fe0a-4223-9bf3-a31d1bf26ec3
https://cris.maastrichtuniversity.nl/en/publications/67c56a38-fe0a-4223-9bf3-a31d1bf26ec3
Autor:
Audrey J. King, Johannes A. Bogaards, Fiona R. M. van der Klis, Suzan Leussink, Marianne A B van der Sande, Petra J. Woestenberg, Birgit H B van Benthem, Christian J. P. A. Hoebe
Publikováno v:
Poster Presentations.
Background Because men who have sex with men (MSM) are disproportionally affected by human papillomavirus (HPV) related cancers, countries might consider targeted HPV vaccination for MSM. We assessed the prevalence of vaccine-preventable HPV types am
Autor:
Pär Sparén, Elaine W. Flagg, Petra J Woestenberg, Teresa M. Imburgia, Marc Steben, Cosette M. Wheeler, Lauri E. Markowitz, Eva Herweijer, Bette Liu, Mari Nygård, Hammad Ali, Kevin G.J. Pollock, Clare Tanton, Christian Munk, Marie-Claude Boily, Pam Sonnenberg, David Mesher, Marc Brisson, Susanne K. Kjaer, Bo T. Hansen, Marta Checchi, Suzanne M. Garland, Basil Donovan, Julia M.L. Brotherton, Jeannie Oliphant, Erich V. Kliewer, Linda M. Niccolai, Shelley L Deeks, Vincenzo Baldo, Denton Callander, Bo Nancy Yu, Gina Ogilvie, Julia W Gargano, Christopher Harrison, Eric P F Chow, Nathalie Grün, Tina Dalianis, Christian Dehlendorff, Jessica A. Kahn, Élodie Bénard, Anne M Johnson, Christopher K Fairley, Anna Söderlund-Strand, Mélanie Drolet, Paul Brassard, Kimberley Kavanagh, Dorothy A Machalek, Norma Pérez, Megan Smith, Maria Jesús Purriños-Hermida, Silvia Cocchio
Summary Background More than 10 years have elapsed since human papillomavirus (HPV) vaccination was implemented. We did a systematic review and meta-analysis of the population-level impact of vaccinating girls and women against human papillomavirus o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcbf3f7d31d072ea425ed9b5560e46fc
http://hdl.handle.net/10044/1/67301
http://hdl.handle.net/10044/1/67301